MIT researchers have been awarded $65.6 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop ingestible devices that could be used to treat diabetes, obesity, and other conditions through oral delivery of mRNA.

MIT is a renowned institution for education and research, offering insights into science, engineering, and technology. Through publications, research papers, and academic programs, MIT's platform provides insights into  research, innovation, and education in various fields. Students, researchers, and technology enthusiasts can learn about MIT's contributions to science and technology and explore opportunities for academic and professional development.

MIT News

MIT researchers have received $65.67 million funding to develop ingestible devices for treating metabolic diseases such as diabetes and obesity. The project aims to utilize mRNA and electroceuticals to deliver therapies orally and stimulate the body's own hormones and neural signaling. Collaborators include Brigham and Women’s Hospital, New York University, and the University of Colorado School of Medicine.

MIT-led team receives funding to pursue new treatments for metabolic disease